10-K/A: Ultralife Corporation Files Amendment No. 1 to Annual Report on Form 10-K

Ultralife Corporation has filed an amendment to its annual report to include previously omitted information regarding directors, executive compensation, and corporate governance.

Summary

• Ultralife Corporation filed Amendment No. 1 to its Annual Report on Form 10-K to include information previously omitted from the original filing.
• The amendment includes details about the company's directors, executive officers, corporate governance, and executive compensation.
• The original Form 10-K was filed on March 21, 2024, and this amendment is being filed because the company will not file a definitive proxy statement within 120 days of the fiscal year-end.
• The company plans to file its definitive proxy statement on or about May 28, 2024, and will hold its 2024 Annual Stockholders Meeting on July 16, 2024.
• The amendment restates Part III, Items 10 through 14, and Part IV, Item 15 of the original Form 10-K in their entirety.
• The company has included new certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
• This amendment does not change any financial information from the original Form 10-K or reflect events that occurred after the original filing date.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing, but the need for an amendment and the severance costs for the former CEO are slightly negative. The company's governance structure and compensation practices are positive.

Positives

• The company has a well-defined corporate governance structure with independent directors and active committees.
• The company has a clear compensation structure for both directors and executive officers.
• The company has implemented stock ownership guidelines to align the interests of executives and stockholders.
• The company has a short-term incentive plan (STIP) that rewards performance based on financial metrics.
• The company has a long-term incentive plan that uses stock options to incentivize long-term growth.
• The company has a code of ethics that emphasizes conducting business in a legal and ethical manner.

Negatives

• The company had to file an amendment to its annual report due to the omission of required information.
• The company's former CEO, Michael D. Popielec, was terminated in 2022, resulting in significant severance costs of approximately $779,000.
• The company's stock ownership guidelines require named executive officers to hold a certain amount of stock, which may be a challenge for some executives to achieve within the required timeframe.

Risks

• The company faces risks associated with the conduct of its business, which are managed through an enterprise risk management process.
• The company's Audit and Finance Committee has oversight responsibility for financial and cybersecurity risks.
• The company's stock price could be affected by various factors, including market conditions and company performance.
• The company's ability to attract and retain qualified directors and executive officers is crucial for its success.

Future Outlook

The company plans to file its definitive proxy statement on or about May 28, 2024, and will hold its 2024 Annual Stockholders Meeting on July 16, 2024.

Management Comments

• Michael E. Manna, President and Chief Executive Officer, stated that the report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
• Philip A. Fain, Chief Financial Officer and Treasurer, stated that the report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

Industry Context

This filing is a standard regulatory requirement for publicly traded companies and provides transparency to investors regarding the company's governance, executive compensation, and financial practices. The company operates in the battery industry, which is experiencing growth due to the increasing demand for energy storage solutions.

Comparison to Industry Standards

• The director compensation structure, with annual retainers and committee fees, is typical for micro-cap public companies.
• The use of stock options and short-term incentive plans is a common practice to align executive compensation with company performance.
• The stock ownership guidelines for directors and executives are in line with industry best practices to ensure long-term commitment.
• The company's corporate governance structure, with independent directors and active committees, is consistent with NASDAQ listing standards.
• Comparable companies in the battery industry include EnerSys (ENS), Saft Groupe SA (SFT.PA), and QuantumScape Corporation (QS), although these companies may have different market capitalizations and business models.

Stakeholder Impact

• Shareholders will receive more complete information about the company's governance and compensation practices.
• Employees will be affected by the company's compensation and incentive plans.
• Customers and suppliers will not be directly impacted by this filing.

Next Steps

• The company will file its definitive proxy statement on or about May 28, 2024.
• The company will hold its 2024 Annual Stockholders Meeting on July 16, 2024.

Key Dates

Keywords

Ultralife Corporation, Annual Report, Form 10-K, Amendment, Directors, Executive Officers, Corporate Governance, Executive Compensation, Stock Options, Incentive Plan, Board of Directors, Audit Committee, Financial Reporting, Battery Industry